Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 26 for:    acute myeloid gemtuzumab children

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (Myechild01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02724163
Recruitment Status : Recruiting
First Posted : March 31, 2016
Last Update Posted : May 11, 2018
Sponsor:
Collaborators:
Assistance Publique - Hôpitaux de Paris
Cancer Research UK
National Cancer Institute, France
Pfizer
Information provided by (Responsible Party):
University of Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2031
Estimated Study Completion Date : December 2032